Unlock stock picks and a broker-level newsfeed that powers Wall Street.

Munich - Delayed Quote EUR

Onco-Innovations Ltd (W1H.MU)

0.9950
+0.0050
+(0.51%)
At close: May 5 at 9:55:00 PM GMT+2
All All Favorites Text Statistics Technicals Fibonacci Markings Lines
Loading Chart for W1H.MU

Recent News: W1H.MU

View More

Onco-Innovations' Inka Health Signs New Analytical Work with AstraZeneca Canada to Advance Real-World Evidence in Regulatory Science
ACCESS Newswire 11 days ago

Dr. James Orbinski Joins Onco-Innovations' Scientific and Clinical Advisory Board to Bolster Company's Mission
ACCESS Newswire 13 days ago

Onco-Innovations Announces Partnership with Dalton Pharma for Isotope Synthesis of Patented PNKP Technology
ACCESS Newswire 18 days ago

Onco-Innovations Announces Private Placement
ACCESS Newswire 19 days ago

Onco-Innovations’ Inka Health Publishes Roche-Sponsored Study Advancing Real-World Oncology Research
ACCESS Newswire 25 days ago

Onco-Innovations' Inka Health Completes Analytical Work for AstraZeneca Canada, Advancing Pharmaceutical Analytics and Leading to Key Studies at ISPOR 2025
ACCESS Newswire last month

Onco-Innovations' PKNP Technology Used with Radiation Therapy Shown in Study to Demonstrate Low Toxicity and High Safety Profile
ACCESS Newswire last month

Onco-Innovations Extends Marketing Program
ACCESS Newswire last month

Onco-Innovations Provides Update on Use of Proceeds
ACCESS Newswire last month

Onco-Innovations CEO Thomas O’Shaughnessy Featured on Conversations That Matter to Discuss Breakthroughs in Cancer Treatment, AI Integration, and Potential Global Expansion
ACCESS Newswire 2 months ago

Onco-Innovations' Inka Health Innovative AI-Driven Oncology Study Paves the Way for New Research
ACCESS Newswire 2 months ago
View More

Related Tickers

5CV.F CureVac N.V.
3.0680
-2.60%
 
IFRX InflaRx N.V.
1.6500
-4.62%
 
NVAX Novavax, Inc.
6.27
-2.18%
 
MRNA Moderna, Inc.
27.84
+0.83%